Innovative Industrial Properties, Inc. (NYSE:IIPR) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
On January 22, 2019, Innovative Industrial Properties, Inc. posted an investor presentation to its website located at http://investors.innovativeindustrialproperties.com/. A copy of the investor presentation is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
The information contained in this Current Report, including Exhibit 99.1 referenced herein, is being furnished and shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any filing of Innovative Industrial Properties, Inc., whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Item 7.01 Financial Statements and Exhibits.
(d)The following exhibit is furnished herewith:
INNOVATIVE INDUSTRIAL PROPERTIES INC Exhibit
EX-99.1 2 tv511248_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 NYSE: IIPR and IIPR Pr A www. innovativeindustrialproperties .com LEADING PROVIDER OF REAL ESTATE CAPITAL FOR THE MEDICAL – USE CANNABIS INDUSTRY 1 As of January 22,…
To view the full exhibit click here
About Innovative Industrial Properties, Inc. (NYSE:IIPR)
Innovative Industrial Properties, Inc. is focused on the acquisition, ownership and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. The Company intends to acquire its properties through sale-leaseback transactions and third-party purchases. It is focused on leasing its properties on a triple-net lease basis, where the tenant is responsible for all aspects of and costs related to the property and its operation during the lease term, including maintenance, taxes and insurance. The Company intends to conduct business in an umbrella partnership real estate investment trust (UPREIT), structure through its operating partnership. The Company’s real estate investments will consist of primarily properties suitable for cultivation and production of medical-use cannabis.
